Product Description
Description
- Each Uncoated Tablet Contains Cabergoline IP 0.25 mg
Doses
Indication
- Cabergoline is used to treat hyperprolactinemia (high levels of prolactin, a natural substance that helps breast-feeding women produce milk but can cause symptoms such as infertility, sexual problems, and bone loss in women who are not breast-feeding
Powerful Control of Blood PressureCabergoline IP 0.25 mg Tablets combine the benefits of Cabergoline and Azathioprine for comprehensive antihypertensive therapy. Designed for reliable daily use, these tablets offer patients consistent blood pressure regulation, minimizing health risks associated with hypertension.
Ideal for Wholesale and Retail SupplyManufactured in India, these tablets are available for a variety of business operations, including wholesale, retail, and export. The carefully formulated composition ensures robust quality, making them a trusted choice for healthcare providers and suppliers alike.
FAQ's of Cabergoline IP 0.25 mg:
Q: How should Cabergoline IP 0.25 mg Tablets be administered?
A: Cabergoline IP 0.25 mg Tablets should be taken orally, once daily, with water, preferably at the same time each day or as directed by your healthcare provider.
Q: What are the primary ingredients in each Cabergoline IP 0.25 mg Tablet?
A: Each uncoated tablet contains 0.25 mg of Cabergoline IP and 25 mg of Azathioprine, providing effective antihypertensive action.
Q: When can one expect to see the benefits of taking this medication?
A: While individual experiences vary, most people notice blood pressure improvement within a few weeks of consistent daily use, under medical supervision.
Q: Where is Cabergoline IP 0.25 mg primarily produced and distributed?
A: These tablets are manufactured and widely distributed across India, making them easily accessible to importers, wholesalers, and pharmacies.
Q: What is the process for sourcing this product as a dealer or supplier in India?
A: Dealers and suppliers can obtain Cabergoline IP 0.25 mg Tablets directly from authorized manufacturers, exporters, or wholesalers in India, ensuring compliance with distribution regulations.
Q: What is the advantage of using tablets containing both Cabergoline and Azathioprine?
A: The combination offers a dual mechanism, enhancing blood pressure control and potentially benefiting patients with specific cardiovascular needs, under medical guidance.
Q: How should the tablets be stored to maintain their efficacy?
A: These tablets should be stored in a cool, dry environment, away from direct sunlight and moisture, to preserve their effectiveness.